Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
about
Osteoclasts are active in bone forming metastases of prostate cancer patientsBone Tumor Environment as a Potential Therapeutic Target in Ewing SarcomaDendritic and mast cell involvement in the inflammatory response to primary malignant bone tumoursGene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications.Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.High Expression of Complement Component 5 (C5) at Tumor Site Associates with Superior Survival in Ewing's Sarcoma Family of Tumour Patients.Osteoprotegerin inhibits bone resorption and prevents tumor development in a xenogenic model of Ewing's sarcoma by inhibiting RANKLDrugs targeting the bone microenvironment: new therapeutic tools in Ewing's sarcoma?TRAIL-based therapy in pediatric bone tumors: how to overcome resistance.Non-Canonical (RANKL-Independent) Pathways of Osteoclast Differentiation and Their Role in Musculoskeletal Diseases.Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.VEGF165 promotes the osteolytic bone destruction of ewing's sarcoma tumors by upregulating RANKL.Metabolic modulation of Ewing sarcoma cells inhibits tumor growth and stem cell properties.Tissue-Engineered Model of Human Osteolytic Bone Tumor.Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones
P2860
Q21090081-BB95AB46-11BA-4CDF-A31A-6825D7C1E3B3Q26771376-A6041D58-B06B-4EA3-B5CE-DC460ACC57FAQ33276145-20D72B43-20A9-4E25-A50F-2F9294B5572AQ33992622-CC3A37B7-DC3E-4F7E-88DB-D823E4BA3202Q35168030-44EBBCB1-8BD0-4E4D-B233-F53E797B1DEAQ35389934-17E4DD0D-2B69-4C1A-A4F2-E115556E47F5Q36491545-E0A1A8AC-F9D6-4F97-A62F-1569E49D8308Q38129954-51A1F42D-6870-41C2-B69C-9A868D7EA428Q38352891-66DD8657-97F4-4D15-B2CD-1195E3E2DC95Q38636476-A28CA764-B0C3-46A1-878D-710D54765018Q39032864-45F9D304-842E-4D11-BD9B-08009C90C465Q39753254-10F7E34C-7933-4387-9857-7F9F47DE47CFQ47101870-6E799538-5249-4803-9CDA-C5E65CBA4838Q48875320-3CCA9680-EB94-45D8-9D8A-0483646B6AC6Q52769260-BA7CF5D1-6F1E-4871-AE3D-58DE7033EE9BQ59195962-24A008C3-DD72-4931-8B60-284F951396A1
P2860
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@ast
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@en
type
label
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@ast
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@en
prefLabel
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@ast
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@en
P2093
P2860
P356
P1476
Cellular and humoral mechanisms of osteoclast formation in Ewing's sarcoma
@en
P2093
A Sabokbar
C L M H Gibbons
N A Athanasou
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603774
P407
P577
2007-05-29T00:00:00Z